Drug utilization evaluation of high-dose methotrexate in a cancer center in north of Iran

Background: Methotrexate (MTX) is commonly used in the hematology-oncology units and is frequently associated with adverse effects. High-dose methotrexate (HDMTX) is indicated in the treatment of acute lymphoblastic leukemia (ALL), osteosarcoma, systemic non-Hodgkin lymphoma and primary central nerv...

Full description

Bibliographic Details
Main Authors: Shadi Khazaei, Shahrbanoo Keyhanian, Mahila Monajati, Shahram Ala, Ebrahim Salehifar
Format: Article
Language:fas
Published: Tehran University of Medical Sciences 2017-12-01
Series:Tehran University Medical Journal
Subjects:
Online Access:http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5642&slc_lang=en&sid=1